Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
deals
3
×
fda
3
×
life sciences
national blog main
boston blog main
boston top stories
investing
new york blog main
startups
the medicines company
480 biomedical
achaogen
adams street partners
alirocumab
alnylam pharmaceuticals
amgen
antibiotics
arsenal medical
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
bob langer
boston
chronic rhinosinusitis
covid-19
drug delivery
drug resistance
drugs
evolocumab
genzyme
george whitesides
hatteras venture partners
inclisiran
inflammation
ipo
keros therapeutics
lyra therapeutics
lyzz capital
macrolide pharmaceuticals
What
company
3
×
drug
medicines
new
therapeutics
acquire
agreed
bacteria
billion
biopharma
biotech
brings
business
cash
cholesterol
compound
deal
debut
developing
disease
exited
fda
fighting
infections
infectious
ipo
late
launches
lyra
markets
medco
melinta
million
nose
noses
novartis
persistently
poised
products
public
Language
unset
Current search:
fda
×
deals
×
company
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections